639 related articles for article (PubMed ID: 31262307)
1. Polycystic ovary syndrome is a risk factor for sarcopenic obesity: a case control study.
McBreairty LE; Chilibeck PD; Gordon JJ; Chizen DR; Zello GA
BMC Endocr Disord; 2019 Jul; 19(1):70. PubMed ID: 31262307
[TBL] [Abstract][Full Text] [Related]
2. Vitamin D Deficiency Is Associated With Metabolic Risk Factors in Women With Polycystic Ovary Syndrome: A Cross-Sectional Study in Shaanxi China.
Wang L; Lv S; Li F; Yu X; Bai E; Yang X
Front Endocrinol (Lausanne); 2020; 11():171. PubMed ID: 32296394
[No Abstract] [Full Text] [Related]
3. Body composition and its association with cardiometabolic risk factors in the elderly: a focus on sarcopenic obesity.
Chung JY; Kang HT; Lee DC; Lee HR; Lee YJ
Arch Gerontol Geriatr; 2013; 56(1):270-8. PubMed ID: 23079031
[TBL] [Abstract][Full Text] [Related]
4. The Prevalence Rate of Adult Sarcopenic Obesity and Correlation of Appendicular Skeletal Muscle Mass Index with Body Mass Index, Percent Body Fat, Waist-Hip Ratio, Basal Metabolic Rate, and Visceral Fat Area.
Luo X; Cai B; Jin W
Metab Syndr Relat Disord; 2023 Feb; 21(1):48-56. PubMed ID: 36318808
[No Abstract] [Full Text] [Related]
5. Sarcopenia, sarcopenic obesity and inflammation: Results from the 1999-2004 National Health and Nutrition Examination Survey.
Batsis JA; Mackenzie TA; Jones JD; Lopez-Jimenez F; Bartels SJ
Clin Nutr; 2016 Dec; 35(6):1472-1483. PubMed ID: 27091774
[TBL] [Abstract][Full Text] [Related]
6. Associations of sarcopenic obesity with the metabolic syndrome and insulin resistance over five years in older men: The Concord Health and Ageing in Men Project.
Scott D; Cumming R; Naganathan V; Blyth F; Le Couteur DG; Handelsman DJ; Seibel M; Waite LM; Hirani V
Exp Gerontol; 2018 Jul; 108():99-105. PubMed ID: 29649572
[TBL] [Abstract][Full Text] [Related]
7. Young obese women with polycystic ovary syndrome have evidence of early coronary atherosclerosis.
Shroff R; Kerchner A; Maifeld M; Van Beek EJ; Jagasia D; Dokras A
J Clin Endocrinol Metab; 2007 Dec; 92(12):4609-14. PubMed ID: 17848406
[TBL] [Abstract][Full Text] [Related]
8. Bioavailable and free 25-hydroxyvitamin D and vitamin D binding protein in polycystic ovary syndrome: Relationships with obesity and insulin resistance.
Naderpoor N; Shorakae S; Abell SK; Mousa A; Joham AE; Moran LJ; Stepto NK; Spritzer PM; Teede HJ; de Courten B
J Steroid Biochem Mol Biol; 2018 Mar; 177():209-215. PubMed ID: 28734987
[TBL] [Abstract][Full Text] [Related]
9. Relationships between sarcopenic obesity and insulin resistance, inflammation, and vitamin D status: the Korean Sarcopenic Obesity Study.
Kim TN; Park MS; Lim KI; Choi HY; Yang SJ; Yoo HJ; Kang HJ; Song W; Choi H; Baik SH; Choi DS; Choi KM
Clin Endocrinol (Oxf); 2013 Apr; 78(4):525-32. PubMed ID: 22563924
[TBL] [Abstract][Full Text] [Related]
10. Sarcopenia and sarcopenic obesity among men aged 80 years and older in Beijing: prevalence and its association with functional performance.
Meng P; Hu YX; Fan L; Zhang Y; Zhang MX; Sun J; Liu Y; Li M; Yang Y; Wang LH; Zhang Y; Gao W; Han XQ; Chen LK
Geriatr Gerontol Int; 2014 Feb; 14 Suppl 1():29-35. PubMed ID: 24450558
[TBL] [Abstract][Full Text] [Related]
11. Associations of Vitamin D with Inter- and Intra-Muscular Adipose Tissue and Insulin Resistance in Women with and without Polycystic Ovary Syndrome.
Scott D; Joham A; Teede H; Gibson-Helm M; Harrison C; Cassar S; Hutchison S; Ebeling PR; Stepto N; de Courten B
Nutrients; 2016 Nov; 8(12):. PubMed ID: 27916865
[TBL] [Abstract][Full Text] [Related]
12. Exploring factors related to changes in body composition, insulin sensitivity and aerobic capacity in response to a 12-week exercise intervention in overweight and obese women with and without polycystic ovary syndrome.
Scott D; Harrison CL; Hutchison S; de Courten B; Stepto NK
PLoS One; 2017; 12(8):e0182412. PubMed ID: 28771628
[TBL] [Abstract][Full Text] [Related]
13. Adiponectin is independently associated with insulin sensitivity in women with polycystic ovary syndrome.
Spranger J; Möhlig M; Wegewitz U; Ristow M; Pfeiffer AF; Schill T; Schlösser HW; Brabant G; Schöfl C
Clin Endocrinol (Oxf); 2004 Dec; 61(6):738-46. PubMed ID: 15579189
[TBL] [Abstract][Full Text] [Related]
14. Lean muscle mass in classic or ovulatory PCOS: association with central obesity and insulin resistance.
Mario FM; do Amarante F; Toscani MK; Spritzer PM
Exp Clin Endocrinol Diabetes; 2012 Oct; 120(9):511-6. PubMed ID: 22576259
[TBL] [Abstract][Full Text] [Related]
15. Osteosarcopenia in Reproductive-Aged Women with Polycystic Ovary Syndrome: A Multicenter Case-Control Study.
Kazemi M; Jarrett BY; Parry SA; Thalacker-Mercer AE; Hoeger KM; Spandorfer SD; Lujan ME
J Clin Endocrinol Metab; 2020 Sep; 105(9):e3400-14. PubMed ID: 32614948
[TBL] [Abstract][Full Text] [Related]
16. Vitamin D in polycystic ovary syndrome: Relationship to obesity and insulin resistance.
Joham AE; Teede HJ; Cassar S; Stepto NK; Strauss BJ; Harrison CL; Boyle J; de Courten B
Mol Nutr Food Res; 2016 Jan; 60(1):110-8. PubMed ID: 26255991
[TBL] [Abstract][Full Text] [Related]
17. Obesity, but not hyperandrogenism or insulin resistance, predicts skeletal muscle mass in reproductive-aged women with polycystic ovary syndrome: A systematic review and meta-analysis of 45 observational studies.
Kazemi M; Pierson RA; Parry SA; Kaviani M; Chilibeck PD
Obes Rev; 2021 Aug; 22(8):e13255. PubMed ID: 33855800
[TBL] [Abstract][Full Text] [Related]
18. Sarcopenic obesity assessed using dual energy X-ray absorptiometry (DXA) can predict cardiovascular disease in patients with type 2 diabetes: a retrospective observational study.
Fukuda T; Bouchi R; Takeuchi T; Tsujimoto K; Minami I; Yoshimoto T; Ogawa Y
Cardiovasc Diabetol; 2018 Apr; 17(1):55. PubMed ID: 29636045
[TBL] [Abstract][Full Text] [Related]
19. Insulin resistance is not strictly associated with energy intake or dietary macronutrient composition in women with polycystic ovary syndrome.
Toscani MK; Mario FM; Radavelli-Bagatini S; Spritzer PM
Nutr Res; 2011 Feb; 31(2):97-103. PubMed ID: 21419313
[TBL] [Abstract][Full Text] [Related]
20. Comparison of regional fat mass measurement by whole body DXA scans and anthropometric measures to predict insulin resistance in women with polycystic ovary syndrome and controls.
Glintborg D; Petersen MH; Ravn P; Hermann AP; Andersen M
Acta Obstet Gynecol Scand; 2016 Nov; 95(11):1235-1243. PubMed ID: 27529295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]